908 Devices Inc. (MASS)

NASDAQ: MASS · Real-Time Price · USD
3.740
-0.160 (-4.10%)
Apr 3, 2025, 4:00 PM EDT - Market closed
-4.10%
Market Cap 132.13M
Revenue (ttm) 59.63M
Net Income (ttm) -72.21M
Shares Out 35.33M
EPS (ttm) -2.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 539,571
Open 3.670
Previous Close 3.900
Day's Range 3.575 - 3.810
52-Week Range 1.810 - 7.480
Beta 0.30
Analysts Buy
Price Target 5.33 (+42.51%)
Earnings Date Apr 29, 2025

About MASS

908 Devices Inc., a commercial-stage technology company. The company provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. It also provides include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the ex... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Dec 18, 2020
Employees 246
Stock Exchange NASDAQ
Ticker Symbol MASS
Full Company Profile

Financial Performance

In 2024, 908 Devices's revenue was $59.63 million, an increase of 18.72% compared to the previous year's $50.23 million. Losses were -$72.21 million, 98.4% more than in 2023.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for MASS stock is "Buy." The 12-month stock price forecast is $5.33, which is an increase of 42.51% from the latest price.

Price Target
$5.33
(42.51% upside)
Analyst Consensus: Buy
Stock Forecasts

News

908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld devices for chemical analysis, announces that it has received a $1.7 million order from the Ministry of He...

23 days ago - Business Wire

908 Devices Makes Key Divestiture (Rating Upgrade)

908 Devices' stock surged after announcing a $70 million desktop portfolio sale, doubling its cash position and improving financial stability. The company will now focus on its handheld device busines...

4 weeks ago - Seeking Alpha

908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth

On Tuesday, Repligen Corporation RGEN purchased 908 Devices Inc.'s MASS desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications.

Other symbols: RGEN
4 weeks ago - Benzinga

908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter and full year ...

4 weeks ago - Business Wire

Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices

WALTHAM, Mass., & BOSTON--(BUSINESS WIRE)--Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer i...

Other symbols: RGEN
4 weeks ago - Business Wire

908 Devices to Participate in Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the following investor c...

4 weeks ago - Business Wire

908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the fourth quarter and f...

4 weeks ago - Business Wire

908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced preliminary unaudited financial results for the...

2 months ago - Business Wire

Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters

BOSTON--(BUSINESS WIRE)-- #automation--Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge's bioreactors with 908 Devices' MAVEN for automated control ...

3 months ago - Business Wire

908 Devices Inc. (MASS) Q3 2024 Earnings Call Transcript

908 Devices Inc. (NASDAQ:MASS) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Kelly Gura - Gilmartin Group Kevin Knopp - Chief Executive Officer and Co-Founder Joe...

5 months ago - Seeking Alpha

908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter ended Septembe...

5 months ago - Business Wire

908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the third quarter 2024 b...

5 months ago - Business Wire

908 Devices to Participate in Craig-Hallum Bioprocessing Conference

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the upcoming virtual Cra...

7 months ago - Business Wire

908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter ended June 30,...

8 months ago - Business Wire

25 Snack Food Suppliers Queue Up for ReposiTrak's Rapidly Expanding Food Traceability Network

SALT LAKE CITY--(BUSINESS WIRE)--As regulatory deadlines approach, 25 snack food suppliers align with ReposiTrak for its state-of-the-art, hardware-free traceability solutions.

8 months ago - Business Wire

908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the upcoming Canaccord G...

8 months ago - Business Wire

908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the second quarter 2024 ...

9 months ago - Business Wire

908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, has appointed Michele M. Leonhart, the former Administrator of ...

10 months ago - Business Wire

908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors

BOSTON--(BUSINESS WIRE)-- #hazmat--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced an enhanced quantification package fo...

10 months ago - Business Wire

Lab Instrument Industry Update - New Commercial Entrants

Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry h...

11 months ago - Seeking Alpha

908 Devices Inc. (MASS) Q1 2024 Earnings Call Transcript

908 Devices Inc. (NASDAQ:MASS) Q1 2024 Results Conference Call April 30, 2024 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Co-Founder and Chief Executive Officer Joe ...

1 year ago - Seeking Alpha

908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarte...

1 year ago - Business Wire

908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biochemical analysis, announces that it has completed the a...

1 year ago - Business Wire

908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the firs...

1 year ago - Business Wire

908 Devices: Rare Early-Stage Bioprocess Investment Opportunity

Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies are leading companies in the life science tools industry. Despite a long history of success with those firms, I believe long-ter...

1 year ago - Seeking Alpha